Skip to content

Live Events

Live Events

Live Events

Live Events

Library

By pinki shah / May 14, 2022

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 976 - 1,000 of 2,995

«
1
…
38
39
40
41
42
…
120
»

Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations

Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations

By: Mark S, Shahin, MD, FACOG, FACS

Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations

Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations

By: Mark S, Shahin, MD, FACOG, FACS

Novel Advances in Ovarian and Uterine Cancers

Novel Advances in Ovarian and Uterine Cancers

By: Mark S. Shahin, MD, FACOG, FACS

New Directions in the Management of Ovarian Cancer

New Directions in the Management of Ovarian Cancer

By: Mihaela Cristea - MD

State of the Art in Gynecologic Oncology

State of the Art in Gynecologic Oncology

By: Rebecca A. Brooks, MD

State of the Art in Gynecologic Oncology

State of the Art in Gynecologic Oncology

By: Rebecca A. Brooks, MD

Therapeutic Advances in Gynecologic Oncology

Therapeutic Advances in Gynecologic Oncology

By: Rebecca Brooks, MD

Therapeutic Advances in Gynecologic Oncology

Therapeutic Advances in Gynecologic Oncology

By: Rebecca Brooks, MD

Current Status of Cervical Cancer Screening

Current Status of Cervical Cancer Screening

By: Ritu Salani MD, MBA

Current Status of Cervical Cancer Screening

Current Status of Cervical Cancer Screening

By: Ritu Salani MD, MBA

Gynecologic Malignancies: New Targeted Therapy-IO-Chemo Combinations

Gynecologic Malignancies: New Targeted Therapy-IO-Chemo Combinations

By: Ritu Salani, MD, MBA

Gynecologic Malignancies: New Targeted Therapy-IO-Chemo Combinations

Gynecologic Malignancies: New Targeted Therapy-IO-Chemo Combinations

By: Ritu Salani, MD, MBA

Immunotherapy For Uterine Cancer New Standards For Upfront Treatment For Advanced Or Recurrent Disease

Immunotherapy For Uterine Cancer New Standards For Upfront Treatment For Advanced Or Recurrent Disease

By: Ritu Salani, MD, MBA

Incorporating Immunotherapy in the Management of Cervical Cancer

Incorporating Immunotherapy in the Management of Cervical Cancer

By: Susana Campos, MD, MPH

Gynecologic Cancer Recent Advances in Management

Gynecologic Cancer Recent Advances in Management

By: Tate Thigpen, MD

Gynecologic Cancer

Gynecologic Cancer

By: Tate Thigpen, MD

Immunotherapies in Gynecologic Malignancies

Immunotherapies in Gynecologic Malignancies

By: Thomas Herzog, MD

Targeted Therapies in Ovarian & Other Gynecologic Cancers

Targeted Therapies in Ovarian & Other Gynecologic Cancers

By: Thomas J Herzog, MD

Immunotherapies in Gynecologic Malignancies

Immunotherapies in Gynecologic Malignancies

By: Thomas J Herzog, MD

Immunotherapy in Gynecologic Malignancies

Immunotherapy in Gynecologic Malignancies

By: Thomas J. Herzog, MD

Targeted Therapies in Ovarian & Other Gynecologic Cancers

Targeted Therapies in Ovarian & Other Gynecologic Cancers

By: Thomas J. Herzog, MD

New Directions in the Management of Ovarian Cancer

New Directions in the Management of Ovarian Cancer

By: Mihaela C. Cristea, MD

Ovarian cancer: Contemporary Management & Clinical Trial Endpoint Considerations

Ovarian cancer: Contemporary Management & Clinical Trial Endpoint Considerations

By: Thomas J. Herzog, MD

Ovarian Cancer: Contemporary Management & Clinical Trial Endpoint Considerations

Ovarian Cancer: Contemporary Management & Clinical Trial Endpoint Considerations

By: Thomas J. Herzog, MD

Head and Neck Cancer 2024 Updates

Head and Neck Cancer 2024 Updates

By: Cristina P. Rodriguez, MD

«
1
…
38
39
40
41
42
…
120
»

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok